Eagle Health Investments Lp Top Holdings and 13F Report (2025) About Eagle Health Investments LpInvestment ActivityEagle Health Investments Lp has $405.17 million in total holdings as of June 30, 2025.Eagle Health Investments Lp owns shares of 21 different stocks, but just 12 companies or ETFs make up 80% of its holdings.Approximately 12.86% of the portfolio was purchased this quarter.About 15.44% of the portfolio was sold this quarter.This quarter, Eagle Health Investments Lp has purchased 20 new stocks and bought additional shares in 1 stock.Eagle Health Investments Lp sold shares of 8 stocks and completely divested from 3 stocks this quarter.Largest Holdings Insmed $43,134,304argenex $42,680,965Natera $39,863,758Illumina $32,760,073Icon $29,495,806 Largest New Holdings this Quarter 91324P102 - UnitedHealth Group $18,995,229 Holding10806X102 - BridgeBio Pharma $11,196,574 Holding40131M109 - Guardant Health $11,032,480 Holding80706P103 - Scholar Rock $9,542,148 Holding Largest Purchases this Quarter UnitedHealth Group 60,888 shares (about $19.00M)BridgeBio Pharma 259,300 shares (about $11.20M)Guardant Health 212,000 shares (about $11.03M)Scholar Rock 269,400 shares (about $9.54M)argenex 2,440 shares (about $1.34M) Largest Sales this Quarter Exact Sciences 164,900 shares (about $8.76M)Natera 43,800 shares (about $7.40M)DexCom 83,100 shares (about $7.25M)Alnylam Pharmaceuticals 19,570 shares (about $6.38M)Insmed 14,700 shares (about $1.48M) Sector Allocation Over TimeMap of 500 Largest Holdings ofEagle Health Investments Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorINSMInsmed$43,134,304$1,479,408 ▼-3.3%428,60010.6%MedicalARGXargenex$42,680,965$1,344,977 ▲3.3%77,43010.5%MedicalNTRANatera$39,863,758$7,399,572 ▼-15.7%235,9649.8%MedicalILMNIllumina$32,760,0730.0%343,3618.1%MedicalICLRIcon$29,495,806$930,880 ▼-3.1%202,7907.3%MedicalNBIXNeurocrine Biosciences$27,299,868$992,951 ▼-3.5%217,2006.7%MedicalDXCMDexCom$23,901,835$7,253,799 ▼-23.3%273,8215.9%MedicalRAREUltragenyx Pharmaceutical$22,819,5360.0%627,6005.6%MedicalBMRNBioMarin Pharmaceutical$20,163,656$868,526 ▼-4.1%366,8125.0%MedicalUNHUnitedHealth Group$18,995,229$18,995,229 ▲New Holding60,8884.7%MedicalPRCTPROCEPT BioRobotics$17,227,5260.0%299,0894.3%MedicalALNYAlnylam Pharmaceuticals$15,028,184$6,381,581 ▼-29.8%46,0863.7%MedicalAKROAkero Therapeutics$12,080,7040.0%226,4003.0%MedicalEXASExact Sciences$11,890,075$8,762,786 ▼-42.4%223,7502.9%MedicalBBIOBridgeBio Pharma$11,196,574$11,196,574 ▲New Holding259,3002.8%MedicalGHGuardant Health$11,032,480$11,032,480 ▲New Holding212,0002.7%MedicalAGIOAgios Pharmaceuticals$11,003,4060.0%330,8302.7%MedicalSRRKScholar Rock$9,542,148$9,542,148 ▲New Holding269,4002.4%MedicalISRGIntuitive Surgical$2,385,5700.0%4,3900.6%MedicalIMCRImmunocore$1,452,8940.0%46,3000.4%MedicalVIRVir Biotechnology$1,212,1200.0%240,5000.3%MedicalINSPInspire Medical Systems$0$12,920,953 ▼-100.0%00.0%MedicalASNDAscendis Pharma A/S$0$8,806,090 ▼-100.0%00.0%MedicalTMDXTransMedics Group$0$6,772,472 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
